{"name":"Quan Dong Nguyen","slug":"quan-dong-nguyen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNNTFERVYtZlBJTlBWTWNRS1BFRG1vVVA2VjNpckNoVUthU0p2bHhmWVUzQy1GRzdIMXRudUNPUmswdHBMZDVfRnVMeFcza0EzZk83dFVQeF81Sm4yR0lnMjkxOWJNakpmcDJJYWExcHV5VWt2ZG8yTUp3elRwOHc2WmdhTGR2dmdHWVNTai1DOFpiUmhnNGlnem50MEhmMTlTSEw4cEZRajlsQVhOVV8tRVgxWHUzSXpTc1E?oc=5","date":"2025-12-17","type":"pipeline","source":"Ophthalmology Times Europe","summary":"FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen - Ophthalmology Times Europe","headline":"FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQNWlSQlgwZkl6dmhJSElNVTYyZlhaNlAtZHZ0QU1NNTlINW1nN0NPb2hVM2FqUlVoODF0NmZ5ajhiVUFGdHRRR3paUS13dHB0Y1BKYmhzYjR1dGNrTTlfOGFfamZpeU80YjZJRF9tajcwTHJtTkluY3lxZ3NJcnNEOWdwV3ZRcm9YakhUZEw0V0laaDJpYWhLVQ?oc=5","date":"2025-12-01","type":"regulatory","source":"Fierce Biotech","summary":"Belite brings FDA filing into view with phase 3 Stargardt disease victory - Fierce Biotech","headline":"Belite brings FDA filing into view with phase 3 Stargardt disease victory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9HOERFYkptTXhJQUtiNF9JdjQ1ZU41cm5ZQkxrR0FzYmk2b2p4ankwT2RBbjVreTQxY0gySkc2Rnl1NXp3LW8zQ2stdzBZUUg4NnBMUDZHa0I3dEwwSWdJRE5CdnFyMmxKODdVSDBBd0NfUDZEUlFBdW1n?oc=5","date":"2024-07-19","type":"pipeline","source":"MedPage Today","summary":"Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis - MedPage Today","headline":"Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0RXRadEdJcjBERi1SLXd4bnVEWkpHc2ZpYllaT3pUSTBvVmVzeENleHVaczV6Vkd3cnVqdlV4eDhkRVVOQUw2ZE5HREtqWEVvd3FJTzRiZzNlQnZJclFZ?oc=5","date":"2024-04-15","type":"pipeline","source":"nature.com","summary":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy - nature.com","headline":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQN0NRWEJ6NzhwQ0NDdkExQW9fZXNHTVpKX2tUbmtoUzdvY3czXzBTZzRpeE5pcDc3NklTdTVsZGRDRzI2VjdkeXV5cjZZRHVENHVIdGktVjBhYzJMb0dENGd5dnJXV291djJPVVRvaTY4NWVGWFRDbEZ6c2VyWV9KVHZlVXRWVXRxOUotQ3dkc2VfUXhqYmNXaEFncW8wWXBDaUZUeVNmdlkxaHEyMThFeGlXZnB2UW55LWI2b3p5VGVQQQ?oc=5","date":"2024-04-02","type":"trial","source":"drugtopics.com","summary":"Brepocitinib Shows Positive Results For Treatment of Non-Infectious Uveitis in Phase 2 Study - drugtopics.com","headline":"Brepocitinib Shows Positive Results For Treatment of Non-Infectious Uveitis in Phase 2 Study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMElCeFlKdFliOHRNUWRNcXRuZmdPNlEwcHp6dnc0T2pSMW5TNjZYTEpMY2FxRktoMVpWZ0pkSF9MU0g4eHY4OXVwYVhfSFI0U25nRXhMeVhFaGtGekZlUG5WSDlqbTI0Tmxxd3htWDI1U1BiUzJZamdJMlVrUjU3djFERHROWkQ2V2pfYWpGQkMtMXl4RGZEWFRPckF4UWlKVFlsUktPV3JJRENZVkYybEtGY1lmaG5UTUF3?oc=5","date":"2023-11-14","type":"regulatory","source":"Ophthalmology Times","summary":"Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis - Ophthalmology Times","headline":"Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPYk5ZZWpwaWhkT0EzNGRLRE1vdWtOYXh4Z2ZJZnFnSUVmdkFPT28xZWF2THpDUjNjZGpJUS1LZWtxZUZkMUpMVFpBRmpPN2pLZUowVVVXa041TktHWkltTDdNNWF0Y1p3cXg3SWlraFUwRmNOV19kdDREMjNnMXljdlB3MHhtTG9TM2ZLajBtdHlGbFJjaXhDSmpUSVNCZnNHaDNCU2tLRmxQbTlWVnA4OTRhcXA?oc=5","date":"2020-11-19","type":"pipeline","source":"Renal and Urology News","summary":"Risk for Ophthalmic Problems Not Higher With HIF-PHI Use - Renal and Urology News","headline":"Risk for Ophthalmic Problems Not Higher With HIF-PHI Use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNcThFWmRxTFBpRzlPQWY5aWRxV0d5QUhqb19oVG0ydUJuYVVjNjh3Mmo1T20zNmZnUEdieFlTNVdyZldjSENwTkJ4WUI0YnJPbFVGSjFuQ2dNQllRblZYQ0p4T1ZQWktGTjZjdWxDd0RXYk9IaXVXMTNqQzVURzBrREFHR2pqYUVtbFE2YUc3VWtHZEoyVUk5VGdmaEM?oc=5","date":"2019-01-11","type":"pipeline","source":"Modern Retina","summary":"IL-6 inhibition shows promise as treatment for non-infectious uveitis - Modern Retina","headline":"IL-6 inhibition shows promise as treatment for non-infectious uveitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1CLW1GQTNPTURnS1FvZkFHUnFxSjZKOUxrM1c3SmR5RW8yVno3Q1A1elc4WVh2VFJDQm9tQ3pnRGtWX0lsSEYzWFUxSjZVbmg5VF9sLWk3Mm44RGI5dDJqcnRtY24xaWJ0WG1ieQ?oc=5","date":"2018-06-18","type":"trial","source":"ARVO Journals","summary":"The SATURN Study (SARIL-NIU): Sarilumab for the Treatment of Posterior Segment Non-Infectious Uveitis (NIU) - ARVO Journals","headline":"The SATURN Study (SARIL-NIU): Sarilumab for the Treatment of Posterior Segment Non-Infectious Uveitis (NIU)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQc2dfVnVUQ1VkUVBFeTdyZmdwZEVnTkV4a3BfQVpLOS1fdEtHTU1ENlYwOVRxbGhXNkw2WGt2SmE0OWxyWTdDMVBVR281QUJINzZ1ZmFiTmdLb2JfdUlOaVJnWURGSHZxaVZIVnQ3eGU1YTh3MllidW5WeGZCOEp0Nzh3?oc=5","date":"2015-01-10","type":"pipeline","source":"Healio","summary":"Range of uveitis treatments set to expand - Healio","headline":"Range of uveitis treatments set to expand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNMW9FbS1ZZTlrSUo3TnU5c2YtSm1Qd1hjR3BqR1FXeDltV1FFRnJSanRTUE1CSFNxVUZWbzd2R0hTNUwxV1V2NVEzYmFjOV9zZVhBbFlpbUdmb0p2eVI3dFE0X0pLTUlFQ1Noa0tkalZxNHlVbG4xbjVCNEFFRElQc3pWSllGN3ZJTDBMOEcxdjJxa2tLbzNGcg?oc=5","date":"2012-11-07","type":"pipeline","source":"University of Nebraska Medical Center","summary":"Dr. Quan Dong Nguyen named chairman of ophthalmology - University of Nebraska Medical Center","headline":"Dr. Quan Dong Nguyen named chairman of ophthalmology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQbEN1ajdOaUcwOURhaFJXbm0yUXhXelRxZUhRUW5Lemk5RndvcFB1WmNTQWpWSmNiUHhiVkhlTG4xRWx3djVDQjhfaldTdHhiWTRUUGlSSjFuRkxPZzU5bE1QVW9oQzE0UzhnZTRjVWs1Qjl5UEItM3RZSjBqWk5kS2g2Tk9JeVExNDN5eWx1anRCUF9ETUMzSXJYVFVzVm81S2tVczFzRXJHTTk2QjNFckplcU5ROGFnTnVn?oc=5","date":"2012-11-05","type":"pipeline","source":"University of Nebraska Medical Center","summary":"Quan Dong Nguyen, Johns Hopkins physician, named chairman of UNMC ophthalmology - University of Nebraska Medical Center","headline":"Quan Dong Nguyen, Johns Hopkins physician, named chairman of UNMC ophthalmology","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}